Albireo q3 loss per share $1.73

Albireo reports third quarter 2019 financial results and provides business update.q3 loss per share $1.73.q3 revenue $1.4 million versus $200,000.q3 revenue estimate $959,000 -- refinitiv ibes data.q3 earnings per share estimate $-1.56 -- refinitiv ibes data.albireo pharma - for fy 2019, anticipates total expenses, including research and development and g&a expenses, to be in range of $70 million-$75 million.continues to anticipate that current cash balance will be sufficient to meet operating needs into 2021.
ALBO Ratings Summary
ALBO Quant Ranking